Open Dataset · DOI 10.5281/zenodo.24139315Fecha: 2026-11-11 · Dallas, TX
Archivo Oficial · 35 Comunicados
4 DOIs Permanentes CERN/Zenodo
Sala de Prensa, Comunicados Oficiales y Datos Abiertos de Losing Weight RX
Archivo oficial de auditorías de precios de telesalud GLP-1, estudios de cobertura de seguros y bases de datos científicas abiertas publicadas por el equipo de farmacoeconomía de Losing Weight RX (Dallas, TX). Contacto de prensa e investigación: [email protected].
Comunicados de Prensa Verificados (35)
Open Dataset · DOI 10.5281/zenodo.24139325Fecha: 2026-11-11 · Dallas, TX
Losing Weight RX Releases 2026 Commercial Insurance GLP-1 Prior-Authorization Denial Study
Open Dataset · DOI 10.5281/zenodo.24139333Fecha: 2026-11-11 · Dallas, TX
Losing Weight RX Audits Absorbed-Dose Economics Across Injectable, Oral, and IV Lounge NAD+ and Glutathione
Clinical Cost BenchmarkFecha: 2026-11-11 · Dallas, TX
Losing Weight RX Publishes Comparative Cost and Absorption Benchmark for Needle-Free Sublingual GLP-1 Tablets
Open Dataset · DOI 10.5281/zenodo.24139340Fecha: 2026-11-11 · Dallas, TX
Losing Weight RX Launches 50-State and D.C. Telehealth GLP-1 Prescribing Law and Medicaid Access Directory
Interactive Consumer ToolsFecha: 2026-11-11 · Dallas, TX
Losing Weight RX Introduces Five Free Pharmacoeconomic Tools Including a U-100 Vial Unit Converter
Consumer Fee WatchdogFecha: 2026-11-11 · Dallas, TX
Losing Weight RX Consumer Watchdog Report Exposes Telehealth Membership Dues and High-Dose Surcharges
Open Research PortalFecha: 2026-11-11 · Dallas, TX
Losing Weight RX Establishes Open-Access Pharmacoeconomic Research Portal With 467 Verified Clinical Cost Records
Consumer Pricing AuditFecha: 2026-11-09 · Dallas, TX
Losing Weight RX Analyzes Out-of-Pocket Expenditure Trends in Telehealth Weight Loss
HSA & FSA GuideFecha: 2026-11-09 · Dallas, TX
Losing Weight RX Details HSA and FSA Reimbursement Strategies for Online Obesity Care
Regulatory AdvisoryFecha: 2026-11-09 · Dallas, TX
Losing Weight RX Releases 2026 National Pharmacy Supply and Compounding Regulation Advisory
Clinical EducationFecha: 2026-11-09 · Dallas, TX
Losing Weight RX Publishes Evidence-Based Protocol Guide for First-Time GLP-1 Patients
Fee WatchdogFecha: 2026-11-09 · Dallas, TX
Losing Weight RX Evaluates Telehealth Subscription Fees Versus Flat-Rate Incretin Care
Telehealth OperationsFecha: 2026-11-09 · Dallas, TX
Losing Weight RX Compares Virtual Consultation Standards and Pharmacy Delivery Speeds
Tirzepatide Cost AuditFecha: 2026-11-09 · Dallas, TX
Losing Weight RX Issues 2026 Direct Sourcing and Cost Analysis for Compounded Tirzepatide
Provider ComparisonFecha: 2026-11-09 · Dallas, TX
Losing Weight RX Releases Head-to-Head Out-of-Pocket Telehealth Price Comparison Report
Fee WatchdogFecha: 2026-11-09 · Dallas, TX
Losing Weight RX Audits Digital Weight Loss Membership Dues and Hidden Surcharges for 2026
Semaglutide Cost AuditFecha: 2026-11-09 · Dallas, TX
Losing Weight RX Publishes 2026 Direct Price Audit on Compounded Semaglutide Telehealth Providers
Longevity & RecoveryFecha: 2026-11-07 · Dallas, TX
Losing Weight RX Publishes 2026 Black Friday Sermorelin Peptide Consultation and Wellness Guide
Seasonal Pricing ReportFecha: 2026-11-07 · Dallas, TX
Losing Weight RX Releases Dual-Incretin Black Friday Consultation Report With Zero Subscription Club Dues
Fee TransparencyFecha: 2026-11-07 · Dallas, TX
Losing Weight RX Publishes 2026 Black Friday Telehealth Consultation Directory and Fee Transparency Report
Cellular WellnessFecha: 2026-11-07 · Dallas, TX
Losing Weight RX Publishes 2026 Black Friday Injectable Glutathione Report: Clinical Superiority Over Oral Supplements
Fee TransparencyFecha: 2026-11-07 · Dallas, TX
Losing Weight RX Publishes 2026 Black Friday Telehealth Consultation Directory and Fee Transparency Report (Edition 1)
Consumer WatchdogFecha: 2026-11-06 · Dallas, TX
Online Telehealth Red Flags: 7 Warning Signs of Deceptive Pricing and Hidden Recurring Fees
Retail Pharmacy CrisisFecha: 2026-11-06 · Dallas, TX
Retail Brand Out-of-Pocket Crisis: Why $1,050/mo Ozempic and Mounjaro Drive Patients to Telehealth
Provider AuditFecha: 2026-11-06 · Dallas, TX
Calibrate and WeightRx Review: Patient Sentiment Analysis on Customer Service Delays and Pharmacy Shortages
Dose-Escalation AuditFecha: 2026-11-06 · Dallas, TX
Compounded Tirzepatide From 2.5mg to 15mg: Platforms That Don't Increase Price as Dose Doubles
Insurance AppealsFecha: 2026-11-06 · Dallas, TX
Commercial GLP-1 Insurance Denial Toolkit: How to Appeal Prior Authorization Denials
Patient ContinuityFecha: 2026-11-06 · Dallas, TX
Switching GLP-1 Providers: How to Transfer Prescriptions Without Being Forced Back to Starting Doses
Contract WarningFecha: 2026-11-06 · Dallas, TX
Avoid 12-Month Upfront GLP-1 Contracts: Consumer Warning on Non-Refundable Telehealth Packages
Provider AuditFecha: 2026-11-06 · Dallas, TX
OrderlyMeds vs Direct Telehealth: Delivery Velocity, Partner Pharmacies, and Total Annual Expense
Provider AuditFecha: 2026-11-06 · Dallas, TX
Mochi Health Review: In-Depth Cost Analysis of Compounded Incretins Plus Subscription Dues
Provider AuditFecha: 2026-11-06 · Dallas, TX
Hims & Hers Weight Loss Review: Real Patient Costs of Oral Compounded vs Injectable Options
Provider AuditFecha: 2026-11-06 · Dallas, TX
Ro Body Membership Cost vs Direct Care: Analyzing the $1,200/Year Fee on Top of Medication
Fee WatchdogFecha: 2026-11-06 · Dallas, TX